NADINE P LINDSAY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family WILMINGTON, DE NPI 1013417807

General Payments — all program years on this page

$1,736.03

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 50
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $542.52 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $542.5217

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $172.736
2022 $210.565
2023 $810.2222
2024 $542.5217

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086290950 Bayer Healthcare Pharmaceuticals Inc. $20.71 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100326136 Novo Nordisk Inc $20.82 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100584766 Novo Nordisk Inc $58.97 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100599475 Novo Nordisk Inc $24.00 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104335322 AstraZeneca Pharmaceuticals LP $16.49 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107541503 ABBVIE INC. $24.11 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107541505 ABBVIE INC. $25.62 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107541507 ABBVIE INC. $20.31 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107541509 ABBVIE INC. $25.29 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107541511 ABBVIE INC. $24.92 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133670992 Gilead Sciences, Inc. $82.83 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135849399 Lilly USA, LLC $100.00 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135849403 Lilly USA, LLC $18.95 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135909529 Lilly USA, LLC $12.35 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135909531 Lilly USA, LLC $23.50 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139536804 Astellas Pharma US Inc $18.91 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150956277 Neurocrine Biosciences, Inc. $24.74 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.